Last updated on March 2019

S-Equol in Alzheimer's Disease 2 Trial

Brief description of study

By doing this study researchers hope to learn if S-equol, a compound that acts like estrogen in the body, causes an increase in mitochondrial activity. Researchers also hope to determine the safety and tolerability of a therapeutic dose of S-equol and whether or not it influences cognition.

Clinical Study Identifier: NCT03101085

Find a site near you

Start Over